BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24021839)

  • 1. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease.
    Koziolek M; Mühlhausen J; Friede T; Ellenberger D; Sigler M; Huppke B; Gärtner J; Müller GA; Huppke P
    Blood Purif; 2013; 36(2):92-7. PubMed ID: 24021839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
    Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis in treatment of acute inflammatory demyelinating disorders.
    Mühlhausen J; Kitze B; Huppke P; Müller GA; Koziolek MJ
    Atheroscler Suppl; 2015 May; 18():251-6. PubMed ID: 25936333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab use in pediatric central demyelinating disease.
    Beres SJ; Graves J; Waubant E
    Pediatr Neurol; 2014 Jul; 51(1):114-8. PubMed ID: 24768216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis.
    Mar S; Lenox J; Benzinger T; Brown S; Noetzel M
    J Child Neurol; 2010 Jun; 25(6):681-8. PubMed ID: 19808990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute demyelinating disorders: emergencies and management.
    Bunyan RF; Tang J; Weinshenker B
    Neurol Clin; 2012 Feb; 30(1):285-307, ix-x. PubMed ID: 22284064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma exchanges in severe and acute inflammatory demyelinating attacks of the central nervous system].
    Brunot S; Vukusic S; Fromont A; Couvreur G; Mousson C; Giroud M; Confavreux C; Moreau T
    Presse Med; 2011 May; 40(5):e271-8. PubMed ID: 21353760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica.
    Lipphardt M; Mühlhausen J; Kitze B; Heigl F; Mauch E; Helms HJ; Müller GA; Koziolek MJ
    J Clin Apher; 2019 Aug; 34(4):381-391. PubMed ID: 30698295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rescue effect of plasma exchange for neuromyelitis optica.
    Wang KC; Wang SJ; Lee CL; Chen SY; Tsai CP
    J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute disseminated encephalomyelitis in childhood].
    Liptai Z; Ujhelyi E; Mihály I; Rudas G; Barsi P
    Ideggyogy Sz; 2009 Jul; 62(7-8):244-54. PubMed ID: 19685702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.
    Yeh EA; Weinstock-Guttman B; Lincoff N; Reynolds J; Weinstock A; Madurai N; Agarwal N; Buch P; Karpinski M; Ramanathan M
    Mult Scler; 2009 Jul; 15(7):802-10. PubMed ID: 19465453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study.
    Meca-Lallana JE; Hernández-Clares R; León-Hernández A; Genovés Aleixandre A; Cacho Pérez M; Martín-Fernández JJ
    Clin Ther; 2013 Apr; 35(4):474-85. PubMed ID: 23541130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Collongues N; Marignier R; Zéphir H; Papeix C; Fontaine B; Blanc F; Rodriguez D; Fleury M; Vukusic S; Pelletier J; Audoin B; Thouvenot E; Camu W; Barroso B; Ruet A; Brochet B; Vermersch P; Confavreux C; de Seze J
    Neurology; 2010 Sep; 75(12):1084-8. PubMed ID: 20855851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.
    Stork L; Ellenberger D; Beißbarth T; Friede T; Lucchinetti CF; Brück W; Metz I
    JAMA Neurol; 2018 Apr; 75(4):428-435. PubMed ID: 29404583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
    Ehler J; Koball S; Sauer M; Mitzner S; Hickstein H; Benecke R; Zettl UK
    PLoS One; 2015; 10(8):e0134583. PubMed ID: 26244762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.
    Mikaeloff Y; Suissa S; Vallée L; Lubetzki C; Ponsot G; Confavreux C; Tardieu M;
    J Pediatr; 2004 Feb; 144(2):246-52. PubMed ID: 14760270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated Syndrome.
    Ehler J; Koball S; Sauer M; Hickstein H; Mitzner S; Benecke R; Zettl UK
    Ther Apher Dial; 2014 Oct; 18(5):489-96. PubMed ID: 24674271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.